Histone deacetylase enzymes as potential drug targets in cancer and parasitic diseases (original) (raw)

Antitheilerial Activity of the Anticancer Histone Deacetylase Inhibitors

Akash Suresh

Frontiers in Microbiology, 2021

View PDFchevron_right

Stage-specific antileishmanial activity of an inhibitor of SIR2 histone deacetylase

Denis Sereno

Acta Tropica, 2005

View PDFchevron_right

Histone deacetylases as targets for antitrypanosomal drugs

Aline Zuma

Future Science OA

View PDFchevron_right

Histone deacetylase inhibition and the regulation of cell growth with particular reference to liver pathobiology

Leo van Grunsven

Journal of Cellular and Molecular Medicine, 2009

View PDFchevron_right

Substrate and inhibitor specificity of class 1 and class 2 histone deacetylases

Andreas Schwienhorst

Journal of Biotechnology, 2006

View PDFchevron_right

Mechanisms of Selective Anticancer Action of Histone Deacetylase Inhibitors

Saverio Minucci

Cell Cycle, 2005

View PDFchevron_right

Differential protein acetylation induced by novel histone deacetylase inhibitors

Keith Glaser

Biochemical and Biophysical Research Communications, 2004

View PDFchevron_right

Histone deacetylase 8 (HDAC8) and its inhibitors with selectivity to other isoforms: An overview

Sk. Abdul Amin

Review article, 2019

View PDFchevron_right

Rational Development of Histone Deacetylase Inhibitors as Anticancer Agents: A Review

William Figg

Molecular Pharmacology, 2005

View PDFchevron_right

Antiproliferative and Differentiating Activities of a Novel Series of Histone Deacetylase Inhibitors

Mario Bigioni

ACS Medicinal Chemistry Letters, 2010

View PDFchevron_right

FR901228, a Potent Antitumor Antibiotic, Is a Novel Histone Deacetylase Inhibitor

Minoru Yoshida

Experimental Cell Research, 1998

View PDFchevron_right

Current perspective of histone deacetylase inhibitors: A review

IP Innovative Publication Pvt. Ltd.

IP Innovative Publication Pvt. Ltd., 2018

View PDFchevron_right

Antimalarial Activity of Phenylthiazolyl-Bearing Hydroxamate-Based Histone Deacetylase Inhibitors

Victor Melendez

Antimicrobial Agents and Chemotherapy, 2008

View PDFchevron_right

Histone Deacetylase Inhibitor as a Novel Anticancer Agent: A Review

pranit saraswat

2015

View PDFchevron_right

Histone Deacetylase Inhibitors in Cancer Therapy: Latest Developments, Trends and Medicinal Chemistry Perspective

Yan Ivanenkov

Anti-Cancer Agents in Medicinal Chemistry, 2007

View PDFchevron_right

Histone Deacetylase Inhibitors: A New Wave of Molecular Targeted Anticancer Agents

Alfredo Budillon

Recent Patents on Anti-Cancer Drug Discovery, 2007

View PDFchevron_right

Discovery of a potent histone deacetylase (HDAC) 3/6 selective dual inhibitor

pondy murugappan ramanujulu

European Journal of Medicinal Chemistry, 2019

View PDFchevron_right

Lysine Deacetylase Inhibitors in Parasites: Past, Present, and Future Perspectives

Dante Rotili

Journal of Medicinal Chemistry, 2017

View PDFchevron_right

Recent Progress in Histone Deacetylase Inhibitors as Anticancer Agents

Loredana Cappellacci

Current Medicinal Chemistry, 2020

View PDFchevron_right

Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors

Ferenc Boldog

Biochemical Journal, 2008

View PDFchevron_right

Inhibitors of human histone deacetylase with potent activity against the African trypanosome Trypanosoma brucei

Martin Taylor

Bioorganic & Medicinal Chemistry Letters, 2012

View PDFchevron_right

The antileishmanial activity of isoforms 6- and 8-selective histone deacetylase inhibitors

Vishal Patil

Bioorganic & Medicinal Chemistry Letters, 2014

View PDFchevron_right

Development of a histone deacetylase 6 inhibitor and its biological effects

Paul Marks

Proceedings of the National Academy of Sciences, 2013

View PDFchevron_right

Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni

Christoph Grunau

Molecular and Biochemical Parasitology, 2009

View PDFchevron_right

Histone deacetylase inhibitors as a potential therapeutic agent for human cancer treatment

Evangelos Misiakos

Targeted Oncology, 2006

View PDFchevron_right

NAD+-dependent histone deacetylases (sirtuins) as novel therapeutic targets

Urszula Uciechowska

Medicinal Research Reviews, 2009

View PDFchevron_right

A novel histone deacetylase inhibitor identified by high-throughput transcriptional screening of a compound library

byungwoo Ryu

Cancer research, 2000

View PDFchevron_right

Unexpected effect of cyclodepsipeptides bearing a sulfonylhydrazide moiety towards histone deacetylase activity

János Sápi

Bioorganic Chemistry, 2018

View PDFchevron_right

Natural Product Inhibitors of Histone Deacetylases as New Anticancer Agents

Tomris Ozben

Current protein & peptide science, 2018

View PDFchevron_right